|
|
Volumn 34, Issue 3, 2002, Pages 931-933
|
|
Monitoring of immunosuppression after clinical small bowel transplantation
a
a
a
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 2 RECEPTOR;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
INTERLEUKIN 6;
INTERLEUKIN 8;
PREDNISONE;
RAPAMYCIN;
TACROLIMUS;
THYMOCYTE ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOKINE RELEASE;
DESMOID TUMOR;
ENTERIC FEEDING;
GARDNER SYNDROME;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INTESTINE BIOPSY;
INTESTINE TRANSPLANTATION;
LEUKOCYTE COUNT;
POSTOPERATIVE INFECTION;
PRIORITY JOURNAL;
PROCTOCOLECTOMY;
RISK FACTOR;
SHORT BOWEL SYNDROME;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADULT;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INTESTINAL ABSORPTION;
INTESTINE, SMALL;
MONITORING, IMMUNOLOGIC;
PARENTERAL NUTRITION, TOTAL;
POSTOPERATIVE PERIOD;
REPERFUSION;
SHORT BOWEL SYNDROME;
SURVIVAL RATE;
TIME FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
XYLOSE;
|
|
EID: 0036262145
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02676-3 Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (5)
|
